| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |